CDMO News
Ritedose Pharmaceuticals Secures FDA Approval for 0.5% Albuterol Inhalation Solution
Ritedose Pharmaceuticals, a division of The Ritedose Corporation and the largest sterile CDMO in the US specialising in aseptic unit-dose production using Blow-Fill-Seal (BFS) technology, has received approval from the US Food and Drug Administration (FDA) to manufacture and distribute
22 May 2025